BRMS1 and central nervous system cancer: BRMS1 mRNA was overexpressed in gliomas grade 2/3 compared to NB (p < 0.01, mean 8.9 fold), PA (p < 0.01, mean 8.3 fold), and GBM (p < 0.01, mean 6.0 fold).